Identification and characterization of chronic lung allograft dysfunction patients with mixed phenotype: A single‐center study
Authors:
- Stijn E. VerledenSVStijn E. Verleden
- Jan Von Der ThüsenJTJan Von Der Thüsen
- Anke Van HerckAHAnke Van Herck
- Bart M. VanaudenaerdeBVBart M. Vanaudenaerde
- Robin VosRVRobin Vos
- the Leuven Lung Transplant GroupTGthe Leuven Lung Transplant Group
- 20 January 2020
- journal article
- research article
- Published by Wiley in Clinical Transplantation
- Vol. 34 (2) , e13781
Abstract
Rationale: Patients can change chronic lung allograft dysfunction (CLAD) phenotype, especially from BOS to mixed phenotype. Our aim was to further characterize these patients.Method: Mixed CLAD was defined as a restrictive physiology with persistent CT opacities, after initial bronchiolitis obliterans syndrome (BOS) diagnosis. The incidence, prognosis, pulmonary function, radiology, pathology, and airway inflammation were compared between patients with restrictive allograft syndrome (RAS) and mixed CLAD.Result: A total of 268 (44%) patients developed CLAD of which 47 (18%) were diagnosed with RAS “ab initio,” 215 (80%) with BOS, and 6 (2%) an undefined phenotype. Twenty‐five patients developed a mixed CLAD phenotype (24 BOS to mixed and 1 RAS to mixed). Survival after mixed phenotype diagnosis was comparable (P = .39) to RAS. More emphysema patients developed a mixed phenotype (P = .020) compared to RAS ab initio, while mixed CLAD patients had a lower FEV1 (P < .0001) and FEV1/FVC (P = .0002) at diagnosis compared to RAS ab initio. CT scans in patients with the mixed phenotype demonstrated apical predominance of the opacities (P = .0034) with pleuroparenchymal fibroelastosis on histopathology.Conclusion: We further characterized patients with a mixed phenotype of CLAD. Although the survival after diagnosis was comparable to RAS ab initio patients, there was a difference in demography, pulmonary function, radiology, and pathology.Keywords
Funding Information
- KU Leuven (C24/18/073)
This publication has 22 references indexed in Scilit:
- Predictors of survival in restrictive chronic lung allograft dysfunction after lung transplantationThe Journal of Heart and Lung Transplantation, 2016
- Antibody-Mediated Rejection in Lung Transplantation: Clinical Outcomes and Donor-Specific Antibody CharacteristicsAmerican Journal of Transplantation, 2016
- Linking clinical phenotypes of chronic lung allograft dysfunction to changes in lung structureEuropean Respiratory Journal, 2015
- Restrictive chronic lung allograft dysfunction: Where are we now?The Journal of Heart and Lung Transplantation, 2015
- An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndromeEuropean Respiratory Journal, 2014
- A new classification system for chronic lung allograft dysfunctionThe Journal of Heart and Lung Transplantation, 2014
- Bronchiolitis Obliterans Syndrome and Restrictive Allograft SyndromeTransplantation, 2013
- Restrictive allograft syndrome post lung transplantation is characterized by pleuroparenchymal fibroelastosisLaboratory Investigation, 2013
- Restrictive allograft syndrome (RAS): A novel form of chronic lung allograft dysfunctionThe Journal of Heart and Lung Transplantation, 2011
- Revision of the 1996 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Lung RejectionThe Journal of Heart and Lung Transplantation, 2007